Cryoport, Inc. (CYRX) stock
CYRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 10/3025% above fair value
$19.89−0.21 (-1.04%)
Close on Nov 13, 2026Market cap $1.01BP/E –Yield –
Cryoport ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Cryoport's ebitda for the twelve months ending Sep 30, 2026 was -$12.68M. For fiscal 2025 it was -$9.09M. The highest annual figure on record is $2.42M in fiscal 2021.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$9.09M | – |
| FY2024 | Dec 31, 2024 | -$90.91M | – |
| FY2023 | Dec 31, 2023 | -$73.05M | – |
| FY2022 | Dec 31, 2022 | -$9.14M | -478.0% |
| FY2021 | Dec 31, 2021 | $2.42M | – |
| FY2020 | Dec 31, 2020 | -$20.14M | – |
| FY2019 | Dec 31, 2019 | -$15.26M | – |
| FY2018 | Dec 31, 2018 | -$7.79M | – |
| FY2016 | Mar 31, 2016 | -$8.50M | – |
| FY2015 | Mar 31, 2015 | -$5.40M | – |
| FY2014 | Mar 31, 2014 | -$4.77M | – |
| FY2013 | Mar 31, 2013 | -$5.93M | – |
| FY2012 | Mar 31, 2012 | -$7.09M | – |
| FY2011 | Mar 31, 2011 | -$5.35M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026CQ3 2026 | Sep 30, 2026 | -$2.34M | – |
| Q2 FY2026CQ2 2026 | Jun 30, 2026 | -$3.45M | – |
| Q1 FY2026CQ1 2026 | Mar 31, 2026 | -$3.21M | -810.6% |
| Q4 FY2025CQ4 2025 | Dec 31, 2025 | -$3.68M | – |
| Q3 FY2025CQ3 2025 | Sep 30, 2025 | -$3.52M | – |
| Q2 FY2025CQ2 2025 | Jun 30, 2025 | -$2.35M | – |
| Q1 FY2025CQ1 2025 | Mar 31, 2025 | $452.00K | – |
| Q4 FY2024CQ4 2024 | Dec 31, 2024 | -$4.85M | – |
| Q3 FY2024CQ3 2024 | Sep 30, 2024 | -$5.55M | – |
| Q2 FY2024CQ2 2024 | Jun 30, 2024 | -$70.47M | – |
| Q1 FY2024CQ1 2024 | Mar 31, 2024 | -$10.04M | – |
| Q4 FY2023CQ4 2023 | Dec 31, 2023 | -$47.80M | – |
| Q3 FY2023CQ3 2023 | Sep 30, 2023 | -$10.00M | – |
| Q2 FY2023CQ2 2023 | Jun 30, 2023 | -$11.61M | -5082.4% |
| Q1 FY2023CQ1 2023 | Mar 31, 2023 | -$3.64M | – |
| Q4 FY2022CQ4 2022 | Dec 31, 2022 | -$4.90M | – |
| Q3 FY2022CQ3 2022 | Sep 30, 2022 | -$2.02M | -447.2% |
| Q2 FY2022CQ2 2022 | Jun 30, 2022 | $233.00K | -80.6% |
| Q1 FY2022CQ1 2022 | Mar 31, 2022 | -$2.45M | -166.4% |
| Q4 FY2021CQ4 2021 | Dec 31, 2021 | -$3.06M | – |
| Q3 FY2021CQ3 2021 | Sep 30, 2021 | $581.00K | – |
| Q2 FY2021CQ2 2021 | Jun 30, 2021 | $1.20M | – |
| Q1 FY2021CQ1 2021 | Mar 31, 2021 | $3.70M | – |
| Q4 FY2020CQ4 2020 | Dec 31, 2020 | -$2.48M | – |
| Q3 FY2020CQ3 2020 | Sep 30, 2020 | -$9.90M | – |
| Q2 FY2020CQ2 2020 | Jun 30, 2020 | -$5.00M | – |
| Q1 FY2020CQ1 2020 | Mar 31, 2020 | -$2.76M | – |
| Q4 FY2019CQ4 2019 | Dec 31, 2019 | -$53.17K | – |
| Q3 FY2019CQ3 2019 | Sep 30, 2019 | -$11.56M | – |
| Q2 FY2019CQ2 2019 | Jun 30, 2019 | -$1.81M | – |
| Q1 FY2019CQ1 2019 | Mar 31, 2019 | -$1.84M | – |
| Q4 FY2018CQ4 2018 | Dec 31, 2018 | -$1.96M | -2782.0% |
| Q3 FY2018CQ3 2018 | Sep 30, 2018 | -$1.95M | – |
| Q2 FY2018CQ2 2018 | Jun 30, 2018 | -$2.27M | – |
| Q1 FY2018CQ1 2018 | Mar 31, 2018 | -$1.61M | – |
| Q4 FY2016CQ1 2016 | Mar 31, 2016 | $72.90K | – |
| Q3 FY2016CQ4 2015 | Dec 31, 2015 | -$2.61M | – |
| Q2 FY2016CQ3 2015 | Sep 30, 2015 | -$1.77M | – |
| Q1 FY2016CQ2 2015 | Jun 30, 2015 | -$1.57M | – |
| Q4 FY2015CQ1 2015 | Mar 31, 2015 | -$2.58M | – |
See a number that looks wrong?